Dr. Sing-Ting Wang completed her internal medicine and hematology-oncology subspecialty training at China Medical University Hospital. She specializes in hematological diseases, hematologic malignancies, hematopoietic stem cell transplantation, and breast cancer treatment and care. With extensive clinical experience, Dr. Wang is dedicated to delivering high-quality medical services. She employs a multidisciplinary team approach to tailor the best treatment strategies for her patients, helping them improve their quality of life.

Dr. Hsiu-Tzu Wang graduated from the School of Medicine at China Medical University and received comprehensive clinical training at the China Medical University Hospital after graduation. Her areas of expertise include solid tumors, particularly soft tissue sarcoma, osteosarcoma, gastric cancer, pancreatic cancer, biliary tract cancer, colorectal cancer, breast cancer, and gynecological cancers. She is a member physician of the Taiwan Oncology Society and the Taiwan Hospice Organization.

Dr. Chia-Yu Chen is currently an attending physician in the Department of Hematology and Oncology at China Medical University Hospital. She graduated from China Medical University with a double major in Chinese and Western Medicine and has obtained professional certifications in oncology, hematology, and bone marrow transplantation. Her primary focus is on the treatment of breast cancer, head and neck cancer, and hematologic disorders. She is actively involved in multidisciplinary teams for breast cancer, head and neck cancer, lymphoma, and hematopoietic stem cell transplantation. Committed to a patient-centered approach, Dr. Chen strives to deliver high-quality medical care while continuously participating in clinical research to advance medical techniques and improve care for her patients.

Hematologic malignancy, bone marrow transplantation
Breast cancer

Dr. Hsieh Ching-Yun is an attending physician in Hematology and Oncology at the China Medical University Hospital. Dr. Hsieh’s clinical research interests mainly focus on brain tumors, head and neck cancers, and lymphoma. He has participated in numerous international clinical trials related to these diseases and has also led two investigator-initiated clinical trials. Dr. Hsieh is highly active in early-phase clinical trials for anti-cancer drugs, having been involved in numerous anti-cancer drug clinical trials. Additionally, he participated in two Phase I clinical trials for intra-tumoral drug injections.

Dr. Ching-Chan Lin received his MD degree and PhD from China Medical University. He has served as an attending physician in the Division of Hematology and Oncology at China Medical University Hospital since 2010. He specializes in genitourinary cancers, hematologic malignancies, and hematopoietic stem cell transplantation. He is a member of the Taiwan Society of Internal Medicine, Chinese Society of Hematology, Chinese Society of Blood and Bone Marrow Transplantation, and Chinese Society of Oncology.